Decreasing prevalence but increasing importance of left ventricular dysfunction and reoperative surgery in prediction of mortality in coronary artery bypass surgery: Trends over 18 years  by Algarni, Khaled D. et al.
A
C
D
Acquired Cardiovascular Disease Algarni et alDecreasing prevalence but increasing importance of left ventricular
dysfunction and reoperative surgery in prediction of mortality in
coronary artery bypass surgery: Trends over 18 yearsKhaled D. Algarni, MD, MHSc, Abdelsalam M. Elhenawy, MD, PhD, Manjula Maganti, MSc,
Susan Collins, BSc, and Terrence M. Yau, MD, MSc, FRCSCFrom th
Healt
Canad
Disclosu
Dr Yau
Resea
Receive
public
Address
lar Su
Canad
0022-52
Copyrig
doi:10.1
340Objectives: The number of patients referred for coronary artery bypass grafting (CABG) has fallen, whereas
their risk profile appears to be increasing. We evaluated changes in the predictors of hospital mortality among
patients undergoing CABG during a span of 18 years.
Methods:Data were collected prospectively for all patients undergoing isolated CABG (n¼ 23,445) from 1991
to 2008. To examine the effect of time on patients’ risk profiles and outcomes, we divided patients into 3 time
cohorts (1991-1996, n ¼ 8280; 1997-2002, n ¼ 9801; 2003-2008, n ¼ 5364). We used multivariable logistic
regression model to identify predictors of mortality in the entire cohort and in each time cohort.
Results: Hospital mortality declined from 2.4% (1991-1996) to 1.2% (2003-2008; P<.0001). Urgent or emer-
gency surgery, left ventricular dysfunction, reoperative CABG, increased age, female gender, hypertension, car-
diogenic shock, congestive heart failure, peripheral vascular disease, left main disease, and earlier year of
operation (1991-1996) were independent predictors of hospital mortality. The prevalence of most risk factors
for mortality increased over the 18-year period of this study. In contrast, the prevalence of severe left ventricular
dysfunction and reoperative CABG decreased significantly; however, their associated odds of mortality in-
creased with time.
Conclusions:Whereas the prevalence of most risk factors increased with time, left ventricular dysfunction and
reoperative CABG became significantly less common. However, the odds of mortality associated with these 2
predictors increased, indicating that although they occur less commonly, these 2 risk factors paradoxically play
an increasingly important role in determining patient outcomes. (J Thorac Cardiovasc Surg 2012;144:340-6)Supplemental material is available online.
During the past 2 decades, increasingly older patients with
more comorbidities have been referred to cardiac surgeons
for coronary artery bypass grafting (CABG). Despite in-
creasing patient risk factors over time, many studies have
shown consistent improvement in operative outcomes.1-4
Over the past decade, however, many cardiac centers have
noted decreasing volumes of isolated CABG. Aldea and col-
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The Journal of Thoracic and Cardiovascular Surgthevolumeof percutaneous coronary interventions (PCIs) in-
creased by 71%. This reduction inCABGvolumesmay have
multiple effects, including an impact on hospital outcomes.
A number of studies have reported associations between hos-
pital volumes and outcomes,6-8 although this relationship
remains controversial. In the context of decreasing
volumes and increasing risk profiles for patients
undergoing isolated CABG, we analyzed our experience
during an 18-year period to evaluate changes in patient risk
profiles, document their outcomes, and determine changes
in the independent predictors of hospital mortality.METHODS
Data Collection and Definitions
Clinical, operative, and outcome data were collected prospectively in
a computerized database for 23,445 consecutive patients undergoing iso-
lated CABG at our institution between January 1, 1991, and December
31, 2008. Patients undergoing CABG with other concomitant procedures
were excluded.
The study was approved by our institutional research ethics board. The
primary outcome was hospital mortality, which was defined as any postop-
erative death during the index hospitalization. Variables collected included
age, sex, left ventricular (LV) grade (by LVejection fraction [LVEF]: grade
1, LVEF  60%; grade 2, LVEF 40%-59%; grade 3, LVEF 20%-39%;
grade 4, LVEF< 20%), previous CABG, urgency of operation (semiur-
gent, indicating an operation during the same admission as a cardiacery c August 2012
Abbreviations and Acronyms
BMI ¼ body mass index
CABG ¼ coronary artery bypass grafting
LV ¼ left ventricular
LVEF ¼ left ventricular ejection fraction
OPCAB ¼ off-pump coronary artery bypass
grafting
OR ¼ odds ratio
PCI ¼ percutaneous coronary intervention
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hours of an event; emergency, indicating an operation within 12 hours of an
event), number of diseased coronary arteries, presence of greater than
a 50% stenosis of the left main coronary artery, and severity of angina,
among other data.
Statistical Analyses
All statistical analyses were performed with SAS version 9.2 (SAS In-
stitute, Inc, Cary, NC). To examine the effect of time on patient risk profiles
and outcomes, we divided patients into 3 groups according to the year of
operation (1991-1996, 1997-2002, and 2003-2008). Contingency table
analysis was then used to evaluate changes with time in prevalence of pre-
operative, intraoperative, and postoperative variables. Univariate analyses
were performed with c2 or Fisher’s exact test for categorical variables
and analysis of variance for continuous variables. Variables that had a uni-
variate P value less than .25 or those of known clinical importance were
submitted to a multivariable logistic regression model using a stepwise
backward elimination method to calculate risk-adjusted mortality and
factor-adjusted odds ratios (ORs). Model discrimination was evaluated
by the area under the receiver–operator characteristic curve, and calibration
was assessed with the Hosmer-Lemeshow goodness-of-fit statistic. The
model was evaluated for multicolinearity with the variance inflation factor
where variance inflation factor less than 2.5 indicates multicolinearity.
RESULTS
Baseline Characteristics and Survival
A total of 23,445 patients underwent isolated CABG be-
tween 1991 and 2008. A trend in volume of isolated CABG
over the 18-year span is depicted in Figure 1. The number of
patients increased progressively from 1991, peaked in 19980
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FIGURE 1. Trends in number of patients undergoing isolated coronary ar-
tery bypass grafting between 1991 and 2008.
The Journal of Thoracic and Ca(n ¼ 1829), and then decreased substantially, by almost
70%, from 1998 to 2008.
Preoperative patient characteristics are detailed in
Table 1. The prevalence of most risk factors increased
steadily. The rate of left main disease almost doubled be-
tween the first and the last time cohort (18.6% vs 33.3%).
The number of patients undergoing semiurgent surgery has
increased over the last 2 cohorts, whereas the number of pa-
tients undergoing elective, urgent, or emergency surgery has
declined significantly. The prevalence of patients with LV
dysfunction (LVEF<60%) has decreased over time, from
70% in the first time cohort to 50% in the last one. The prev-
alence of reoperative CABG declined as well. The changing
risk profile of patients undergoing CABG during this
18-year span is depicted in Figure E1.
Intraoperative variables and postoperative outcomes are
detailed in Table 2. The overall in-hospital mortality de-
clined significantly from 2.4% in the first time cohort to
1.2% in the last one. Although the duration of intensive
care unit stay has fluctuated, the duration of hospital stay
declined significantly with time. Trends of postoperative
outcomes are shown in Figure 2.
Predictors of Hospital Mortality
Analysis of the 23,445 patients undergoing operation
during the entire 18-year period of the study using stepwise
multivariable logistic regression showed the following fac-
tors to be independent predictors of hospital mortality: in-
creased age, female gender, hypertension, peripheral
vascular disease, LV dysfunction, cardiogenic shock, con-
gestive heart failure, reoperative CABG, left main disease,
urgency of surgery, and earlier year of operation (Table E1).
Emergency CABG carried the most significant risk (OR,
4.5), followed by LVEF less than 20% (OR, 4.2) and then
reoperative CABG (OR, 3).
Trends in Multivariable Risk Factors for Hospital
Mortality
The changing trends in independent predictors of hospital
mortality by time cohort are detailed in Table 3. Unadjusted
hospital mortality associated with individual predictors is
shown in Figure E2.
LV dysfunction. Moderate (LVEF 20%-39%) and severe
(LVEF<20%) LV systolic dysfunction were predictors of
hospital mortality in the first time cohort. In the second co-
hort, however, LVEF did not predict mortality. LV systolic
dysfunction then reappeared as a significant predictor of
mortality in the last time cohort. The overall mortality for
patients with an LVEF less than 20% declined significantly
from 11.1% in the first time cohort to 6.4% and 6.3% in the
second and the third time cohorts, respectively. Similarly,
for patients with an LVEF of 20% to 39%, the observed
mortality declined from 3.6% in the first time cohort to
1.8% in the second and 2.3% in the last time cohort.rdiovascular Surgery c Volume 144, Number 2 341
TABLE 1. Preoperative patient’s baseline characteristics by year group
Variable 1991-1996 1997-2002 2003-2008 P value
No. of patients 8280 9801 5364
Age (y) mean  SD 62  9.8 63.6  9.9 65.3  10.1 <.0001
Less than 65 (%) 56.4 49.9 45.3 <.0001
65-74 (%) 34.5 36.5 35.1
75 (%) 9.0 13.6 19.7
BMI (mean  SD) 27.5  4.8 27.9  5.1 28.3  5.2 <.0001
Female (%) 20.7 21.5 21.2 .40
Diabetes mellitus (%) 24.5 30.7 37.3 <.0001
Hypertension (%) 50.8 58.7 72.9 <.0001
Hyperlipidemia (%) 56.7 73.8 91.2 <.0001
Positive family history (%) 66.5 61.03 59.3 <.0001
Angina (%)
Stable 33.8 35.8 37.2 <.0001
Crescendo 33.4 32.0 29.7
Acute coronary insufficiency 30.8 29.9 24.9
Preoperative MI (%) 16.8 21.5 23.3 <.0001
Preoperative cardiogenic shock (%) 1.3 1.2 1.2 .7
Congestive heart failure (%) 8.9 9.3 10.1 .04
Preoperative IABP (%) 3.8 3.1 3 .01
LVEF (%)
>60% 29.7 36.8 49.1 <.0001
40%-60% 45.1 41.6 33.2
20%-40% 22.0 19.0 16.0
<20% 3.2 2.6 1.8
Left main disease (%) 18.6 21.2 33.3 <.0001
Triple-vessel disease (%) 74.4 76.1 82.3 <.0001
Preoperative stroke (%) 8.2 8.5 8.7 .6
Peripheral vascular disease (%) 14.2 16.4 20.3 <.0001
Reoperative CABG (%) 6.9 4.0 2.6 <.0001
Previous PCI  stents 10.4 8.7 10.5 <.0001
Urgency of surgery (%)
Elective 54.6 49.4 50.6 <.0001
Semiurgent 29.6 41.4 40.1
Urgent 14.4 8.6 9.4
Emergency 1.4 0.5 0.5
SD, Standard deviation; BMI, body mass index;MI, myocardial infarction; IABP, intra-aortic balloon pump; LVEF, left ventricular ejection fraction; CABG, coronary artery by-
pass grafting; PCI, percutaneous coronary intervention.
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significantly with time, the associated ORs for mortality in-
creased over the past decade, from 2.5 in the second time
cohort to 3.8 in the last one.
Reoperative CABG. The prevalence of reoperative
CABG decreased from 6.9% in the first cohort to 2.6%
in the last one. In contrast, the risk of hospital mortality in
this group, relative to patients undergoing primary CABG,
has increased over time (ORs, 2.8, 3.1, and 3.5 in the first,
second and third time cohorts, respectively). Inasmuch as
the mortality of reoperative CABG did not change signifi-
cantly during the entire span of this study, this increase in
ORswas driven largely by improving outcomes in patients
undergoing first-time operations.
Urgency of surgery. Observed mortality for patients un-
dergoing urgent surgery declined in the most recent cohort.342 The Journal of Thoracic and Cardiovascular SurgSimilarly, mortality for patients undergoing elective or
semiurgent surgery declined significantly during the 18-
year span of this study. In contrast, patients requiring emer-
gency CABG continued to be at increased risk. The OR for
mortality associated with emergency surgery has fluctuated
over the 3 time cohorts. It was lowest in the first cohort (OR,
3.5) and higher in the later cohorts (ORs, 12.7 and 7.1).
Age and gender. Patients aged 75 years and older had sig-
nificantly higher hospital mortality than those younger than
75 years, but the mortality for elderly patients decreased
substantially from 5.8% in the first time cohort to 2% in
the last one. Hospital mortality also declined in younger
(<70 years) patients, falling from 1.7% in the first cohort
to 0.8% in the last one.
In the last cohort, hospital mortality among female pa-
tients fell to 1.5% compared with 4% in the first cohort.ery c August 2012
TABLE 2. Operative data and postoperative outcomes by year group
Variable 1991-1996 1997-2002 2003-2008 P value
Intraoperative variables
LITA use (%) 86.1 89.6 91.3 <.0001
RITA use (%) 2.2 5.7 7.9 <.0001
Radial artery use* (%) — 4.1 2.1 <.0001
No. of grafts 3.6  0.9 3.5  0.9 3.4  0.9 <.0001
CPB time (min) 86  29.2 85  32.6 81.1  33.4 <.0001
Crossclamping time (min) 61.7  18.6 63.2  24.2 62.9  28.1 <.0001
Cardioplegia technique (%)
Intermittent cold antegrade 71.7 74.1 86.3 <.0001
Warm or tepid cardioplegia 16.9 10.6 1.6
Retrograde 6 1 0.2
Off pump 0.1 5.1 8.5
Postoperative outcomes
Mortality (%) 2.4 1.4 1.2 <.0001
Inotrope use>30 min (%) 33.8 33.1 38.1 <.0001
Low-output syndrome (%) 8.0 4.8 2.9 <.0001
Postoperative IABP (%) 4.9 3.2 2.2 <.0001
Postoperative MI (%) 2.8 2.7 2.4 .3
Postoperative stroke (%) 1.4 1.2 1.1 .4
Postoperative renal failure (%) 0.8 1.0 1.2 .2
Pulmonary complications (%) 9.9 7.5 8.4 <.0001
Sternal wound infection (%)
Superficial 1.9 1.6 1.2 .006
Deep 0.9 0.8 0.6
Sepsis 0.7 1 1.6 <.0001
Resternotomy for bleeding (%) 1.4 2.4 2.8 <.0001
Transfused patients (%) 50.6 44.3 62.2 <.0001
Units of packed RBC transfused 1.4  2.7 1.2  2.8 1.9  2.7 <.0001
Duration of ventilation (h) 22.6  63.5 14.7  49.7 17.2  60.6 <.0001
Duration of ICU stay (h) 52.8  98.5 45.4  76.4 52.6  129 <.0001
Postoperative hospital stay (d) 9.4  9.4 7.9  9.5 7.7  7.9 <.0001
LITA, Left internal thoracic artery; RITA, right internal thoracic artery;CPB, cardiopulmonary bypass; IABP, intra-aortic balloon pump;MI,myocardial infarction; RBC, red blood
cells; ICU, intensive care unit. *Radial artery data was not collected during the first time cohort (1991-1996).
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FIGURE 2. Trends in hospital outcomes: operative mortality, low-output
syndrome (LOS), postoperative intra-aortic balloon pump (IABP) use, peri-
operative myocardial infarction (MI), postoperative renal failure, stroke,
pulmonary complications (Pulm Comp), superficial sternal incision infec-
tion (Super SI),deep sternal infections (Deep SI), and sepsis. P values are
included in the figure.
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significant difference in observed mortality between men
and women, 1.1% and 1.5%, respectively (P¼ .2). Female
gender was a predictor of hospital mortality during the first
and second time cohorts but not in the last one.
DISCUSSION
We found in this study that the prevalence of most risk
factors that have consistently predicted in-hospital mortality
in previous studies2-4,9-12 increased steadily with time.
These factors included advanced age, female gender,
hypertension, left main disease, preoperative myocardial
infarction, congestive heart failure, and peripheral vascular
disease. This was not a surprise for us; indeed, we and
others have previously reported similar findings.2-4,10-12
What was surprising, however, was the decrease in
prevalence of LV dysfunction and reoperative CABG and
the associated increase in risk of death for these subgroups
in our most recent cohort. This reduction in the prevalence
of reoperative CABG and LV dysfunction, with anrdiovascular Surgery c Volume 144, Number 2 343
TABLE 3. Changing trends in multivariable risk factors by year
group (odds ratios)
Variable 1991-1996* 1997-2002y 2003-2008z
Emergency surgeryx 3.5 12.7 7.1
Urgent surgery — 6.5 3.6
Reoperative CABG 2.8 3.1 3.5
LVEF<20% 6.6 — 3.8
LVEF 20%-40% 2.7 — 2.6
Congestive heart failure 1.7 2.3 2.5
Age 1.050 1.039 1.044
Female sex 1.6 1.7 —
Hypertension 1.5 1.8 —
CABG, Coronary artery bypass grafting; LVEF, left ventricular ejection fraction. The
numbers in the last three columns represent odds ratios. *The area under the ROC
curvewas 0.78. The Hosmer-Lemeshow goodness-of-fit P value was .5. yThe area un-
der the receiver–operator characteristic curve was 0.82. The Hosmer-Lemeshow
goodness-of-fit P value was 0.75. zThe area under the receiver–operator characteristic
curve was 0.79. The Hosmer-Lemeshow goodness-of-fit P value was .32.
xEmergency patients from catheterization laboratories or emergency units of same
or other hospitals.
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of death, has not to our knowledge been reported before.
The independent predictors of in-hospital mortality in our
cohort are generally similar to those previously described
by Davierwala, Maganti, and Yau2 with the exception of di-
abetes, which was not found to be a predictor of in-hospital
mortality in our series. Emergency surgery carried the high-
est risk of mortality in our overall series (OR, 4.5; 95% con-
fidence intervals [CI], 2.4-8.4), followed by severe LV
dysfunction (LVEF< 20% [OR, 4.2; 95% CI, 2.7-6.5])
and then reoperative CABG (OR, 3; 95%CI 2.2-4.0). These
findings are in agreement with those of Abramov and col-
leagues,4 who reported urgency of surgery as the strongest
predictor of CABGmortality (OR, 4.5), followed by reoper-
ative CABG and then LVEF less than 35%. Similarly, Jones
and associates10 reported urgency of surgery as the most
significant predictor of mortality after CABG. Davierwala,
Maganti, and Yau2 found LVEF less than 20% as the most
significant predictor of in-hospital mortality, followed by
emergency surgery and then reoperative CABG.LV Dysfunction
Contrary to our initial assumptions, the prevalence of
patients with moderate to severe LV dysfunction
(LVEF<40%) decreased steadily with time. We hypothe-
sized that this decline might be related to a shift of patients
with poor LV function from isolated CABG to combined
CABG and valvular surgery, particularly mitral surgery. Ex-
ploratory analyses of our institutional data demonstrated
a similar reduction in the prevalence of LV dysfunction in
patients undergoing combined aortic valve surgery and
CABG (prevalence of LVEF< 40% of 22.8%, 20.7%,
and 13.8% for the first, second, and third time cohorts, re-
spectively). In contrast, the prevalence of LVEF less than344 The Journal of Thoracic and Cardiovascular Surg40% among patients who underwent combined mitral valve
surgery and CABG has increased progressively with time
(30.6%, 32.8%, and 38.7% for the first, second, and third
time cohorts, respectively). This shift of patients with
LVEF less than 40% from the isolated CABG group to
the combined CABG and mitral valve surgery group over
the past 2 decades appears to explain most of the reduced
prevalence of moderate to severe LV systolic dysfunction
in our patients with isolated CABG. However, our data can-
not clarify whether there was a simultaneous decrease in the
referral of patients with LV dysfunction for CABG in favor
of PCI.
Hospital mortality in patients with significant LV dys-
function (LVEF< 40%) fell by almost 50%, from 4.5%
in the first cohort to 2.3% in the second one, but was essen-
tially unchanged (2.7%) in the last cohort. Surprisingly, the
ORs for mortality associated with LV dysfunction increased
over the past decade, from 2.5 in the second cohort to 3.8 in
the last one. Thus, although LV dysfunction is observed less
commonly in patients with isolated CABG, its relative im-
portance in determining survival has increased rather than
decreased over the past decade.
Whereas moderate (LVEF 20%-39%) and severe LV
dysfunction (LVEF<20%) were both independent predic-
tors of in-hospital mortality for the entire cohort of 23,445
patients, neither level of LV dysfunction was predictive of
mortality in the second cohort (1997-2002), despite the
large sample size of 9801 patients. Other investigators
have also reported that LV dysfunction was no longer pre-
dictive of mortality in the middle of this last decade. Filsoufi
and colleagues13 reported that LVEF less than 30%was not
an independent predictor of early mortality (OR, 1.43; 95%
CI, 0.72-2.86; P ¼ .3). Similarly, Davierwala and associ-
ates,2 who analyzed the impact of LVEF on patients under-
going CABG during 3 time periods from 1990 to 2001,
showed that the impact of LVEF on early mortality declined
over time so that low LVEF no longer predicted mortality in
the last period of their study. Sabik and associates14 also
found that later date of operation decreased mortality in pa-
tients with LV dysfunction (P¼.05), and by the end of their
study, poor LV function was no longer associated with hos-
pital death. In contrast, the most recent cohort of our current
series suggests that as overall results improve, and despite
the decreasing prevalence of LV dysfunction, its relative
importance in determining outcomes is again increasing.
Reoperative CABG
Although the proportion of reoperative CABGs increased
over the 1990s in many centers,14,15 we observed a steady
decrease in reoperative CABG over the past 18 years.
This decline may have been related to more aggressive
use of PCI in patients with graft atherosclerosis, and
perhaps to greater graft longevity, with the near-universal
adoption of aggressive lipid-lowering agents as well asery c August 2012
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not permit more than speculation as to these causes.
Similar to our findings in patients with LV dysfunction,
the ORs for mortality associated with reoperative CABG in-
creased over time, from 2.8 in the first cohort to 3.5 in the
last cohort, even as the prevalence of redo surgery fell. Un-
adjusted mortality among patients undergoing reoperative
CABG decreased from 5.8% in the first time cohort to
3.3% and 3.6% in the second and third cohorts, so it ap-
pears that overall improvements in outcomes are unmasking
a more predictive role of reoperative surgery.
Many studies, including reports frommulticenter registry
data, suggest that redo CABG is still a significant undertak-
ing, with many centers reporting mortality rates from 5% to
12%.14-18 A recent multicenter study by Yap and
associates18 reported results similar to ours, with operative
mortality of 4.8% for redo CABG compared with 1.8% for
first-time CABG (P<.001). After adjustment, redo surgery
remained a predictor for operative mortality (OR, 2.1; 95%
CI, 1.3-3.6).
Urgency of Surgery
The proportion of patients referred for urgent CABG de-
clined in our series from 14.4% in the first cohort to 9.4% in
the last one, whereas the prevalence of truly emergency or
salvage operation decreased from 1.4% to 0.5%. Ferguson
and colleagues12 have reported a similar reduction in the
prevalence of emergency and salvage operations. This
decline is likely attributable to the advances in PCI with
increased operator experience and widespread adoption of
coronary stents,19-21 use of glycoprotein IIb/IIIa
agents,22,23 upfront loading with clopidogrel,24 and the
more recent introduction of percutaneous ventricular assist
devices for high-risk coronary interventions,25 all occurring
over the time span of this series.
Although emergency CABG is less common now, as car-
diologists using catheterization are increasingly able to
stent their way out of trouble, patients now meeting the
criteria for emergency surgery may represent an even
higher-risk subset in which initial salvage attempts have
been unsuccessful and in whom hemodynamic instability
has been prolonged. In this series, the unadjusted mortality
for emergency surgery increased from 7.6% in the first co-
hort to 10.3% in the last one, and the OR for mortality in-
creased from 3.5 in the first cohort to 12.7 and 7.1 in the
subsequent cohorts. Whereas the markedly elevated ORs,
particularly in the second cohort, were associated with a rel-
atively small number of events even in this large group, and
therefore with wide CIs, it is clear that the importance of
emergency CABG in determining survival is increasing
rather than decreasing over time. This trend of decreasing
prevalence of emergency CABG but increasing mortality
was also reported by Haan and colleagues26 in a study of
the Society of Thoracic Surgeons database, in which theyThe Journal of Thoracic and Cafound that the proportion of isolated CABGs performed
on an emergency basis after PCI decreased over the period
from 1994 to 1999 from 2.9% to 0.8%, whereas operative
mortality increased from 8.0% to 9.3% (P<.001).
Other Trends Occurring During the Time Frame of
This Study
The 3 time periods evaluated in this 18-year study corre-
sponded generally to periods of increasing use of balloon
angioplasty, bare metal stents, and drug-eluting stents, re-
spectively. These trends in use of PCI have influenced the
rate of, and risk profile of, patients referred for CABG in
many institutions. We therefore chose to divide this period
of study into 3 equal eras of 6 years.
The prevalence of off-pump CABG (OPCAB) in our in-
stitution increased slightly but steadily over the last 2 eras of
this study, representing 5.1% and 8.5% of CABG cases in
the second (1997-2002) and the latest (2003-2008) eras,
respectively. The overall risk profile of patients who under-
went OPCABwas comparable with that of patients who un-
derwent on-pump CABG, but the prevalence of peripheral
vascular disease was markedly higher in the OPCAB group
(35.8% vs 16.4% and 42.4% vs 20.3% in the second and
the latest eras, respectively). Mortality in OPCAB patients
compared favorably with that in the on-pump group
(0.8% vs 1.4% and 0.9% vs 1.2% in the second and the lat-
est time cohorts, respectively). Despite the higher preva-
lence of peripheral vascular disease among patients
undergoing OPCAB, the prevalence of postoperative stroke
was low, 0% (0/503) and 0.2% (1/455) in the second and
the latest eras of this study, respectively.
There was a small but significant increase in the mean
body mass index (BMI) of our patients over the span of
this study (27.5 4.8, 27.9 5.1, and 28.3 5.2 in the first,
second, and third eras, respectively; P<.0001). Most pa-
tients (93%) had a BMI in the 18 to 35 range. About 6%
of patients had a BMI greater than 35 and a few patients
(<1%) had a BMI less than 18. Extremely high BMI
(>35) was associated with higher morbidity, manifested
mainly as a higher prevalence of postoperative superficial
(4.1%) and deep (2.2%) sternal infections. As well, these
patients tended to have a slightly higher mortality (2.1%),
although this difference did not reach statistical signifi-
cance. Patients with extremely low BMI (<18) had a signif-
icantly higher risk of mortality (5.2%, 4/77) and stroke
(3.9%, 3/77) compared with other patients (P ¼ .008).
Despite the prospective nature of the data collection, this
study remains a retrospective review of a single center’s ex-
perience and therefore has all of the caveats of such a study.
Although the experience of other cardiac surgical units over
the past 2 decades may have varied to some degree, we be-
lieve that the trends observed at our institution are likely
representative of those occurring in other tertiary and qua-
ternary institutions. Two decades of coronary surgeryrdiovascular Surgery c Volume 144, Number 2 345
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medical therapy for coronary disease changed. A long ob-
servation period has advantages as well, including many
years of data available for analysis and the ability to evalu-
ate the potential effects of gradual changes in referral pat-
terns and surgical approaches. Because our data do not
include information on all patients evaluated by the cardiol-
ogists, however, we cannot separate the effects of changes
in referral patterns from cardiologists from changes in ac-
ceptance for surgery by surgeons. Finally, although our da-
tabase accurately captures LV systolic dysfunction, it
unfortunately does not permit analysis of diastolic dysfunc-
tion, which may explain the limited correlation between
poor LVEF and the prevalence of congestive heart failure.
In summary, our study showed a decreasing prevalence of
the 3 risk factors previously identified as most predictive of
hospital mortality, including LV systolic dysfunction, reo-
perative CABG, and emergency surgery. Despite their de-
clining prevalence, the ORs for mortality associated with
all 3 predictors increased over the 18-year span of this se-
ries, as overall results continued to improve in the past de-
cade, but the results in these 3 subgroups of patients
remained constant. Despite previous advances in the care
of patients with LV dysfunction and those who need reoper-
ative or emergency CABG, these patients remain a chal-
lenge to cardiac surgeons and require novel strategies to
improve outcomes further.References
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FIGURE E1. Risk profile of patients undergoing isolated coronary artery
bypass grafting (CABG) stratified by era of surgery. Patient age, hyperten-
sion (HTN), diabetes mellitus (DM), preoperative myocardial infarction
(MI), congestive heart failure (CHF), peripheral vascular disease (PVD),
left main disease (L-Main), and triple-vessel disease (TVD) increased sig-
nificantly with time. Reoperative CABG (R-CABG), patients with poor left
ventricular ejection fraction (LVEF<40%), and urgent/emergency opera-
tions (UrgþEmerg) decreased significantly with time. P values are included
in the figure.
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FIGURE E2. Observed operative mortality for all patients undergoing
emergency (Emerg), coronary artery bypass grafting (CABG), urgent
CABG (Urgent), patients with left ventricular ejection fraction (LVEF)
less than 40%, reoperative (Redo) CABG), patients 75 years or older, fe-
male patients, patients with congestive heart failure (CHF), cardiogenic
shock, and left main disease (LM). P values are included in the figure.
TABLE E1. Multivariable predictors of mortality in the entire cohort (n ¼ 23,445)
Variable n Regression coefficient OR 95% CI P value
Constant 9.36  0.48
Age* — 0.04  0.01 1.0 1.0-1.1 <.0001
Female gender 4,956 0.46  0.12 1.6 1.3-2.0 <.005
Hypertension 13,856 0.44  0.12 1.6 1.2-2.0 .01
Cardiogenic shock 289 0.69  0.24 2.0 1.3-3.2 .004
Congestive heart failure 2,190 0.61  0.14 1.8 1.4-2.4 <.0001
Peripheral vascular disease 3,869 0.56  0.12 1.8 1.4-2.2 <.0001
Reoperative CABG 1,108 1.09  0.16 3.0 2.2-4.0 <.0001
Left main disease 5,400 0.33  0.12 1.4 1.1-1.8 .004
LVEFy
<20% 609 1.43  0.23 4.2 2.7-6.5 <.0001
20%-40% 4,534 0.69  0.16 2.0 1.5-2.7 <.0001
40%-60% 9,584 0.39  0.15 1.5 1.0-2.0 .008
Urgency of surgery
Semiurgent 751 0.80  0.23 2.2 1.4-3.5 .0004
Urgent 2,537 0.80  0.15 2.2 1.7-3.0 <.0001
Emergency 200 1.50  0.32 4.5 2.4-8.4 <.0001
Year of operation 1991-1996z 8,280 0.80  0.16 2.2 1.6-3 <.0001
OR,Odds ratio; CI, confidence interval; CABG, coronary artery bypass grafting; LVEF, left ventricular ejection fraction. The area under the receiver–operator characteristic curve
was 0.8. The Hosmer-Lemeshow goodness-of-fit P value was .19. *Age is a continuous variable. yOdds ratios were calculated by comparing against LVEF 60%. zOdds ratios
were calculated by comparing against the 2003-2008 time cohort.
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